rareplex® assays: design and analytical validation
Published 4 years ago • 785 plays • Length 11:13Download video MP4
Download video MP3
Similar videos
-
5:17
working with the rareplex® developer kit
-
7:17
rareplex® panel and developer assays for ctc enumeration and characterization
-
56:59
circulating tumor cell analysis: delivering on the promise of liquid biopsy
-
8:18
comprehensive ctc analysis: beyond enumeration to protein biomarkers and cancer cell genomes
-
1:01:06
circulating tumor cells circa 2022
-
54:08
webinar - patient treatment selection & disease monitoring by ctc enumeration
-
5:18
tissue transcriptomics with cytefinder® ii instruments
-
21:16
flow cytometry tutorial | flow cytometry data analysis | flow cytometry gating
-
1:31:25
introduction to cancer bioinformatics i: inferring genomic variation from tumor sequencing data
-
2:58:52
music for deep focus and concentration with binaural beats, brainwave music for studying
-
1:02:27
multimodal tissue imaging and machine learning to advance precision medicine
-
54:30
endpoint assays for the characterization of rare and therapy resistant cells in cancer
-
47:54
genetic variant detection in cancer using ish to track tumor evolution
-
1:23
translational biomarkers for early stage validation of therapeutic hypotheses
-
0:52
baseline liquid biopsy in combination with tissue biopsy to detect ras mutations in mcrc
-
11:04
liquid biopsy talks: circulating tumor cells in the prognosis of ovarian cancer patients
-
1:51
sub-typing waldenström's macroglobulinemia: memory b-cell subtype and plasma cell-like subtype
-
28:06
comprehensive landscape of the tumor microenvironment analyzed with cytof® technology
-
21:39
comprehensive genomic profiling in tumour analysis
-
1:00:22
linking cellular location and patient prognosis in brain tumors
-
0:41
what genomic assay is best suited for the extended endocrine therapy decision?